Discover
TWST
Twist Bioscience Corporation
123.12
1 x 122.00
1 x 123.08
bid
ask
-
1.76
1.41%
1 @ 04:00 PM
122.63 -0.49 (0.40%)
| Ytd | 288.15% | |
| 1y | 345.60% |
120.65
day range
124.97
23.30
52 week range
125.66
| Open | 124.01 | Prev Close | 124.88 | Low | 120.65 | High | 124.97 | Mkt Cap | 7.67B |
| Vol | 0.00 | Avg Vol | 1.79M | EPS | -2.22 | P/E | -55.46 | Forward P/E | -182.64 |
| Beta | 2.16 | Short Ratio | 6.88 | Inst. Own | 119.39% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-03 | 50-d Avg | 89.39 | 200-d Avg | 54.97 | 1yr Est | 105.30 |
| Income Statement | |||
| Total Revenue | 118.38M | ||
| Revenues (USD) | 118.38M | ||
| Cost of Revenue | 55.92M | ||
| Gross Profit | 62.45M | ||
| Operating Expenses | 98.73M | ||
| Research and Development Expense | 18.02M | ||
| Selling, General and Administrative Expense | 80.71M | ||
| Operating Income | -36.28M | ||
| Income Tax Expense | 311.00K | ||
| Net Income | -35.05M | ||
| Net Income Common Stock | -35.05M | ||
| Net Income Common Stock (USD) | -35.05M | ||
| Consolidated Income | -35.05M | ||
| Earnings per Basic Share | -0.56 | ||
| Earnings per Basic Share (USD) | -0.56 | ||
| Earnings per Diluted Share | -0.56 | ||
| Earning Before Interest & Taxes (EBIT) | -34.74M | ||
| Earning Before Interest & Taxes (USD) | -34.74M | ||
| Weighted Average Shares | 62.40M | ||
| Weighted Average Shares Diluted | 62.40M | ||
| Balance Sheet | |||
| Cash and Equivalents | 117.44M | ||
| Cash and Equivalents (USD) | 117.44M | ||
| Investments | 119.62M | ||
| Investments Current | 49.40M | ||
| Investments Non-Current | 70.22M | ||
| Trade and Non-Trade Receivables | 65.06M | ||
| Current Assets | 321.30M | ||
| Property, Plant & Equipment Net | 180.62M | ||
| Total Assets | 672.44M | ||
| Debt Current | 8.63M | ||
| Total Debt | 108.59M | ||
| Current Liabilities | 120.26M | ||
| Debt Non-Current | 99.96M | ||
| Total Liabilities | 226.70M | ||
| Accumulated Retained Earnings (Deficit) | -1.43B | ||
| Accumulated Other Comprehensive Income | -655.00K | ||
| Shareholders Equity | 445.74M | ||
| Shareholders Equity (USD) | 445.74M | ||
| Assets Non-Current | 351.14M | ||
| Total Debt (USD) | 108.59M | ||
| Goodwill and Intangible Assets | 94.93M | ||
| Inventory | 35.16M | ||
| Liabilities Non-Current | 106.44M | ||
| Trade and Non-Trade Payables | 17.04M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 6.78M | ||
| Net Cash Flow from Financing | 3.79M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -5.29M | ||
| Capital Expenditure | -9.76M | ||
| Issuance (Purchase) of Equity Shares | 3.79M | ||
| Net Cash Flow from Investing | -10.20M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -435.00K | ||
| Net Cash Flow from Operations | 1.12M | ||
| Effect of Exchange Rate Changes on Cash | 10.00K | ||
| Share Based Compensation | 18.18M | ||